BRCA2 and pachyonychia congenita: Although the association between PC and BRCA (in particular BRCA2) has been known for decades,33,34 recent studies of BRCA in PC have focused on survival outcomes in patients with BRCA alterations compared to wild type BRCA, providing evidence of the high clinical burden and unmet need for treatment in these patients.